GET DAILY SIGNALSInternational Flavors & Fragrances (IFF) Tops Q3 Estimates, Shares Decline 3% on Guidance
Key Takeaways
- IFF reported third-quarter 2026 revenue of $1.94 billion, up roughly 4% year over year and above the analyst consensus of about $1.91 billion.
- Adjusted earnings per share (EPS) came in at $0.83, ahead of the $0.81 consensus estimate.
- Adjusted operating EBITDA reached $403 million, topping the roughly $391.8 million consensus.
- Organic revenue rose 5% year over year, supported by growth in the Scent, Taste, and Health & Biosciences businesses.
- Despite the beat, shares fell about 3% in after-hours trading as the company’s raised full-year revenue guidance midpoint of $7.55 billion came in slightly below consensus expectations.
Earnings Context and Portfolio Shifts
International Flavors & Fragrances is in the midst of a significant transformation as it prepares to separate its Food Ingredients business. This move should allow the company to concentrate on its higher-growth Taste, Scent, and Health & Biosciences segments. The third-quarter report gave investors a useful checkpoint on whether those core areas can maintain momentum during the divestiture process. IFF has also focused on improving profitability and cash flow, so adjusted EBITDA and free cash flow remain important metrics to follow. With a completed $500 million accelerated share repurchase and the Food Ingredients sale expected to close by mid-2027, the quarter highlighted progress on both operations and portfolio simplification.
Quarterly Results in Detail
IFF reported third-quarter 2026 revenue of $1.94 billion, a roughly 4% increase from $1.87 billion a year earlier and above the consensus estimate of about $1.91 billion. Organic revenue grew 5% year over year on a comparable, currency-neutral basis, led by mid-single-digit growth in the Scent and Taste segments and low-single-digit growth in Health & Biosciences. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Adjusted earnings per share came in at $0.83, exceeding the $0.81 consensus estimate. Adjusted operating EBITDA totaled $403 million, up 6% on a comparable currency-neutral basis and ahead of the approximately $391.8 million consensus. On a GAAP basis, results were weighed down by items including goodwill impairment, divestiture-related costs, and losses tied to assets held for sale, reflecting the ongoing portfolio restructuring.
For the full year, IFF raised its revenue guidance to a range of $7.5 billion to $7.6 billion, from $7.4 billion to $7.6 billion previously, and lifted its adjusted operating EBITDA outlook to $1.55 billion to $1.60 billion. However, the new revenue midpoint of $7.55 billion sat slightly below the roughly $7.589 billion consensus, which investors viewed as a modest negative.
Market Reaction and Sentiment
IFF shares declined about 3% in after-hours trading following the release, even though the company beat on revenue, adjusted EPS, and adjusted EBITDA. The pullback reflected investor focus on the full-year revenue guidance, whose midpoint landed slightly below consensus, as well as the company’s comment that fourth-quarter profitability is expected to be softer, particularly in Health & Biosciences, due to higher costs and planned reinvestments. The reaction suggests the market had priced in strong execution and was looking for a clearer, more positive trajectory into 2027. Ongoing progress on the Food Ingredients separation was viewed favorably, but near-term margin pressures and a cautious guidance tone weighed on sentiment.
Forward Outlook and Monitoring Points
Looking ahead, investors will be watching how IFF balances near-term profitability pressures against its longer-term transformation. The company has flagged that fourth-quarter results, especially in Health & Biosciences, may be softer as it absorbs higher costs and reinvests to strengthen the business. This makes the pace and durability of margin recovery in that segment a central focus heading into the next report.
The Food Ingredients divestiture remains the biggest structural catalyst. Management said the separation is progressing well and remains on track to close by the end of the second quarter of 2027. The completion of the transaction and the eventual deployment of proceeds will shape IFF’s balance sheet and its ability to return capital to shareholders.
Finally, investors should monitor demand trends across the Scent and Taste businesses, currency and input-cost dynamics, and the company’s free cash flow conversion, which management has tied to compensation. Together, these factors will help determine whether IFF can sustain its recent momentum while completing one of the most significant portfolio changes in its history. From what I see, this combination of operational execution and structural change will be key to watch.
Using AI Tools for Deeper Analysis
In my research on names like IFF, I often turn to Tickeron’s AI Screener to quickly filter stocks and ETFs by technical patterns, fundamentals, and AI-driven signals. It helps surface relevant peers and trend setups without spending hours on manual screens, which is especially useful when tracking sector developments around portfolio changes and guidance updates.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
IFF's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for IFF turned positive on October 13, 2026. Looking at past instances where IFF's MACD turned positive, the stock continued to rise in 35 of 52 cases over the following month. The odds of a continued upward trend are 67%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 13, 2026. You may want to consider a long position or call options on IFF as a result. In 47 of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 59%.
IFF moved above its 50-day moving average on October 07, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for IFF crossed bullishly above the 50-day moving average on October 14, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 50%.
Following a +4.21% 3-day Advance, the price is estimated to grow further. Considering data from situations where IFF advanced for three days, in 175 of 306 cases, the price rose further within the following month. The odds of a continued upward trend are 57%.
The Aroon Indicator entered an Uptrend today. In 118 of 213 cases where IFF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 55%.
Bearish Trend Analysis
The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 40 of 67 cases where IFF's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 60%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IFF declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 59%.
IFF broke above its upper Bollinger Band on October 13, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 2 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 7 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 10 (best 1 - 100 worst), indicating outstanding price growth. IFF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 80 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.728) is normal, around the industry mean (2.436). P/E Ratio (86.817) is within average values for comparable stocks, (-18.867). Projected Growth (PEG Ratio) (1.767) is also within normal values, averaging (1.548). Dividend Yield (0.017) settles around the average of (0.039) among similar stocks. P/S Ratio (2.004) is also within normal values, averaging (48.960).
The Tickeron SMR rating for this company is 88 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IFF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a manufacturer of flavor and fragrance products
Industry ChemicalsSpecialty
Advertisement